Bevacizumab Intravenous and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Bevacizumab Intravenous and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bevacizumab
Brand name: Avastin, Mvasi
Synonyms: Bevacizumab
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bevacizumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Bevacizumab Intravenous-Insulin glulisine
- Bevacizumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Bevacizumab Intravenous-Insulin Glulisine (Vials)
- Bevacizumab Intravenous-Insulin glulisine Subcutaneous
- Bevacizumab Intravenous-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab-awwb
- Insulin glargine and lixisenatide Subcutaneous-Bevacizumab-awwb Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Bevespi Aerosphere
- Insulin glargine and lixisenatide Subcutaneous-Bevyxxa
- Insulin glargine and lixisenatide Subcutaneous-Bexarotene
- Insulin glargine and lixisenatide Subcutaneous-Bexarotene (Systemic)